HIGH RISK. Document contains exact red flag language: 'By continuing to use the Application...you are deemed to have accepted the change.' No specific advance notice period is stated (industry standard is 30 days; this only says 'in writing before'). No option to reject a change and keep using the service, refusal to accept means loss of access. Service modifications use weak language ('we will try to give you notice'). This is the most problematic provision in the T&C.
User has unconditional right to terminate account anytime, but company can terminate with immediate effect for vaguely-defined 'serious or repeated breach' without clear appeals process. Account suspension notice requirement is weak ('to the extent reasonably possible'). Data handling after termination is mentioned but retention duration beyond legal requirements is unclear.
Transparent pricing shown in app with EU-compliant 14-day withdrawal right, but that right is heavily qualified: it's eliminated if you book services within 14 days. 7-day satisfaction guarantee provided for Neko Scan specifically. No auto-renewal (one-time purchase model), so ongoing subscription concerns do not apply. Refund timing is reasonable (7-15 days).
Platform IP is owned by company and clearly retained (standard practice), but healthcare data ownership language is ambiguous. Line 88 claims company owns 'all data and information generated' for service improvement except 'personal data', but in healthcare, health information is inherently personal data, creating legal ambiguity about secondary analytics use. No user control or deletion rights over health insights are mentioned.
Company remains responsible for breaches but liability is limited to foreseeable, unavoidable losses not caused by circumstances outside company control or user error. Healthcare-specific disclaimers are strong and clearly state services do not replace healthcare. Doctor accountability is explicit (GMC registration required). Exceptions to liability are defined but somewhat broad. No liability caps mentioned.
Clear 18-year-old age requirement with explicit acceptance mechanism via registration or continued use. Services are well-scoped (medical examinations with risk assessment) with plain-language disclaimers that the service complements but does not replace healthcare. Scope limitations are transparent and reasonable.
T&C heavily defers privacy matters to a separate Privacy Policy document not included here. No specifics on data collection methods, sharing, third-party access, user rights (access/deletion/correction), security practices, or breach notification. This is standard for healthcare but requires separate Privacy Policy review. The data-use clause (line 88) about secondary analytics remains concerning.
Excellent consumer protections: no mandatory arbitration, no class-action waiver, and no jury-trial waiver. Courts are preserved as the dispute mechanism. Choice of law is English law, and forum is English courts with specific carve-outs for Scotland and Northern Ireland. Reasonable for a UK-based healthcare provider. No fee-shifting or restrictive claim deadline mentioned.
No user indemnification clause found. Company does not demand that users 'defend, indemnify and hold harmless' it against claims. User is required to represent compliance with sanctions and anti-corruption laws, and company can terminate for false representations, which is proportional and reasonable. Absence of indemnity clause is strongly consumer-protective.